Riociguat
In Stock•Starting at $26 for 50 mg•Purity ≥ 95%
| CAS No. | 625115-55-1 |
|---|---|
| MDL No. | N/A |
| MF | C20H19FN8O2 |
| MW | 422.40 |
| InChI Key | WXXSNCNJFUAIDG-UHFFFAOYSA-N |
| CAS No. | 625115-55-1 |
|---|---|
| MDL No. | N/A |
| MF | C20H19FN8O2 |
| MW | 422.40 |
| InChI Key | WXXSNCNJFUAIDG-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 95% | $26 | In Stock | |
| 100 mg | 95% | $43 | In Stock | |
| 250 mg | 95% | $72 | In Stock | |
| 1 g | 95% | $86 | In Stock | |
| 5 g | 95% | $418 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Riociguat is a carbamate ester, specifically the methyl ester of {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamic acid. It is used in the treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. It functions as a soluble guanylate cyclase activator and antihypertensive agent. It is classified as a pyrazolopyridine, aminopyrimidine, organofluorine compound, and carbamate ester.
| CAS No. | 625115-55-1 |
|---|---|
| Product Name | Riociguat |